Category: Hong Kong Corporate News

Hong Kong Corporate News

AK Medical Secures International and Domestic Sales for K3 Robotic Systems in 2026 – Business Update

Minichart

May 29, 2026

AK Medical Holdings Limited: Significant Business Update and...

Continue Reading 0

Hong Kong Corporate News

Shanghai Henlius Biotech Begins International Phase 2/3 Clinical Trial of HLX43 and HLX07 for Advanced NSCLC Treatment 1

Minichart

May 29, 2026

Shanghai Henlius Biotech Announces First Patient Dosed in In...

Continue Reading 0

Hong Kong Corporate News

Suzhou Ribo Life Science Submits Phase II Clinical Trial Application for RBD1119 Injection to Treat Coronary Artery Disease 1

Minichart

May 28, 2026

Suzhou Ribo Life Science Announces Phase II Clinical Trial A...

Continue Reading 0

Hong Kong Corporate News

Sinopharm Group Notice of Domestic Shareholders’ Class Meeting and H Share Repurchase Mandate 2026

Minichart

May 28, 2026

Sinopharm Group Co. Ltd. Announces Domestic Shareholders’ Cl...

Continue Reading 0

Hong Kong Corporate News

Sinopharm Group Announces H Shareholders’ Class Meeting and Share Repurchase Mandate 2026

Minichart

May 28, 2026

Sinopharm Group Co. Ltd. Announces H Shareholders’ Class Mee...

Continue Reading 0

Hong Kong Corporate News

CIG Shanghai Announces HK$1.97 Billion Placing of New H Shares Under General Mandate to Support Global Expansion

Minichart

May 28, 2026

CIG Shanghai Announces HK\$1.97 Billion H Share Placement Un...

Continue Reading 0

Hong Kong Corporate News

Antengene Receives China IND Approval for Pivotal Phase III CLINCH-3 Trial of ATG-022 in Advanced CLDN18.2+ Gastric/GEJ Cancer 1

Minichart

May 28, 2026

Antengene Announces CDE Approval for Pivotal Phase III CLINC...

Continue Reading 0

Hong Kong Corporate News

Beijing Biostar Pharmaceuticals Announces Four Utidelone Clinical Trials Selected for 2026 ASCO Annual Meeting – Advanced Breast Cancer, Ovarian Cancer, HER2-Positive Breast Cancer, Prostate Cancer Results 123

Minichart

May 28, 2026

Beijing Biostar Pharmaceuticals: Utidelone Clinical Data Sel...

Continue Reading 0

Hong Kong Corporate News

CT Vision (International) Holdings Announces HK$64.8 Million Fundraising via New Share Subscription and Placing for Renewable Energy and Aerospace Expansion

Minichart

May 28, 2026

CT Vision (International) Holdings Limited Announces Share S...

Continue Reading 0

Hong Kong Corporate News

CA Cultural Technology Group EGM Results, Whitewash Waiver Approval, Special Deals Consent, and Shareholding Changes Announced (May 2026)

Minichart

May 28, 2026

CA Cultural Technology Group - Major Corporate Update ...

Continue Reading 0